Credit: Getty Images The FDA is expected to decide on ... for active immunization to prevent disease caused by chikungunya virus infection in individuals 12 years of age and older.
Valneva (VALN) stock rose after the company posted new Phase 3 trial data for its chikungunya vaccine, Ixchiq, in adolescents aged 12-17. Read more here.
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported further positive Phase 3 data in adolescents for its single-shot chikungunya virus (CHIKV) vaccine, IXCHIQ ® ...
Valneva’s vaccine was highly immunogenic in both dose groups. A full dose of the vaccine exhibited a more robust immune response compared to a half dose by providing protective antibody titers already ...
Valneva has announced positive outcomes from its Phase III VLA1553-321 trial of the single-shot IXCHIQ chikungunya virus ...
Maharashtra witnessed a significant rise in chikungunya cases this year, with 5,757 infections. Patients are experiencing prolonged after-effects like joint pain, fatigue, and neurological ...
Although not listed as a hemorrhagic fever virus, illness caused by CHIKV can ... A definitive diagnosis of Chikungunya infection can be made only with the aid of laboratory support since ...
The existing RT-PCR test systems are time consuming and labor-intensive, with a very high risk of contamination primarily due to post-PCR handling leading to carry over. In addition, the majority ...
NParks is calling for research proposals that aim to fortify Singapore against outbreaks of zoonotic diseases. Read more at straitstimes.com.
This action follows an executive order signed by President Trump on his first day in office to withdraw the United States ...
Two deaths and 16 fresh suspected cases of Guillain-Barré Syndrome (GBS) were reported in Pune and other districts, the ...
Infected mosquitoes spread the chikungunya virus through their bites. The main transmitters are the Aedes aegypti and Aedes albopictus species. The same 2 species of mosquitoes also transmit dengue.